Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 146 results for "bsdm"

BSD Medical Corporation (BSDM)'s Investor and Analyst Conference Call Transcript

BSD Medical Corporation Provides Progress Update on Strategic ...

SALT LAKE CITY, Jan. 29, 2015 (GLOBE NEWSWIRE) -- BSD Medical Corporation (Nasdaq:BSDM) (Company or BSD), a leading provider of medical systems that utilize heat therapy to treat cancer, today provided an update on its strategic plan for the Company ... Consumer Electronics Net, 3 hours ago

2 images for "bsdm", 1 week ago
Celebuzz, 3 weeks ago
American Banking News

BSD Medical net loss worsens in FQ1

s Editor BSD Medical (BSDM -16.7%) FQ1 results: Revenues: $0.8M (-38.5%); COGS: $0.5M (-16.7%); Operating Expenses: $2.4M (+9.1%); Net Loss: ($2M) (-33.3%); Loss Per Share: ($0.05) (-25.0%); Quick Assets: $6.2M (-23.5%); CF Ops: ($1.9M) (-2.2%). ...
 Seeking Alpha2 weeks ago BSD Medical EPS of -$0.05  Seeking Alpha2 weeks ago Insider Buying: Gerhard W. Sennewald Buys 46,000 Shares of BSD Medical Stock (BSDM)  American Banking News2 months ago
Live Trading News

Stocks/ETFs that traded to new 52 week highs/lows

this session New highs (259) outpacing new lows (187) Stocks that traded to 52 week highs: AAT, ACC, ADC, ADVS, ADXS, AEC, AEP, AET, AFFX, AIV, AKR, ALGT, ALK, ALKS, ALR, ANTM, APU, ARE, ATO, AUXL, AVB, AVIV, AWR, AXL, AYN, BAH, BBC, BBN, BBW, ...
 Live Trading News1 week ago

Depomed to Acquire U.S. Rights to NUCYNTA®, NUCYNTA® ER and NUCYNTA®; Amgen Presents New Data Supporting First-Line Use Of Vectibix®

Below is a look at some of the headlines for companies that made news in the healthcare sector on January 15, 2015. Depomed Inc. (NASDAQ: DEPO) announced it has entered into a definitive agreement to acquire the U.S. rights to the NUCYNTA ...
 BioMedReports1 week ago Actinium Initiates cGMP Manufacturing of Iomab-B for Phase 3 Clinical Trial; Celator® Announces Publication Phase 2 Data For CPX-351  BioMedReports2 weeks ago Repros Initiates Two Phase 2B Uterine Fibroid Studies; Intersect ENT Announces Enrollment of First Patient in Phase III Study  BioMedReports1 month ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less